Founded in 1997, Ergomed is a complete, global Phase I-IV clinical development and trial management service partner with leading expertise in developing rare diseases and oncology drugs. Pioneers in rare disease drug development since 1998, Ergomed embody a family & patient-centric approach to recruitment and retention with access to global patients in vital geographical areas. To further strengthen Ergomed CRO’s strong operational footprint and expertise in rare diseases and oncology, Ergomed invested in a strategic US acquisition of MedSource CRO, fully integrated in early 2021. Ergomed has supported and managed clinical development, trial management, pharmacovigilance, and medical information services for over 300 clients in more than 100 countries. For more information about Ergomed, please visit: https://www.ergomedplc.com/ergomedplc.com/
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948